» Articles » PMID: 29094808

Dietary Vitamin K and Association with Hepatic Vitamin K Status in a Yup'ik Study Population from Southwestern Alaska

Abstract

Scope: The relationship between dietary vitamin K and plasma PIVKA-II concentration, a biomarker of hepatic vitamin K status, in a Yup'ik study population in southwestern Alaska is investigated.

Methods And Results: A total of 659 male and female, self-reported Yup'ik people, ≥14 years of age, were enrolled. Blood is collected for genotyping and plasma PIVKA-II biomarker analysis. A Yup'ik-specific dietary food frequency questionnaire is used to assess vitamin K intake. Among the participants, 22% report not consuming foods rich in vitamin K during the past year and 36% have a PIVKA-II concentration ≥ 2 ng mL , indicating vitamin K insufficiency. The odds of an elevated PIVKA-II concentration are 33% lower in individuals reporting any versus no consumption of vitamin-K-rich foods. The association is significant after adjusting for CYP4F2*3 genotype. Tundra greens are high in vitamin K1 content, but an exploratory analysis suggests that subsistence meat sources have a greater effect on vitamin K status.

Conclusions: A substantial proportion of the Yup'ik population exhibits vitamin K insufficiency, which is associated with low consumption of vitamin K rich foods and which might affect an individual's response to anticoagulant drugs such as warfarin that target the vitamin K cycle.

Citing Articles

Implementation of a text messaging intervention to patients on warfarin therapy in Brazilian primary care units: a quasi-experimental study.

Souza-Silva M, Domingues M, Chagas V, Pereira D, de Sa L, Almeida M BMC Prim Care. 2022; 23(1):54.

PMID: 35321654 PMC: 8942053. DOI: 10.1186/s12875-022-01647-5.


Advancing precision public health using human genomics: examples from the field and future research opportunities.

Roberts M, Fohner A, Landry L, Olstad D, Smit A, Turbitt E Genome Med. 2021; 13(1):97.

PMID: 34074326 PMC: 8168000. DOI: 10.1186/s13073-021-00911-0.


Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.

Mozrzymas R, Walkowiak D, Drzymala-Czyz S, Krzyzanowska-Jankowska P, Dus-Zuchowska M, Kaluzny L Nutrients. 2020; 12(6).

PMID: 32545860 PMC: 7353192. DOI: 10.3390/nu12061772.


P450 Pharmacogenetics in Indigenous North American Populations.

Henderson L, Claw K, Woodahl E, Robinson R, Boyer B, Burke W J Pers Med. 2018; 8(1).

PMID: 29389890 PMC: 5872083. DOI: 10.3390/jpm8010009.

References
1.
Willems B, Vermeer C, Reutelingsperger C, Schurgers L . The realm of vitamin K dependent proteins: shifting from coagulation toward calcification. Mol Nutr Food Res. 2014; 58(8):1620-35. DOI: 10.1002/mnfr.201300743. View

2.
Holmes M, Hunt B, Shearer M . The role of dietary vitamin K in the management of oral vitamin K antagonists. Blood Rev. 2011; 26(1):1-14. DOI: 10.1016/j.blre.2011.07.002. View

3.
Suttie J, Shah D, Lyle B, Greger J . Vitamin K deficiency from dietary vitamin K restriction in humans. Am J Clin Nutr. 1988; 47(3):475-80. DOI: 10.1093/ajcn/47.3.475. View

4.
Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M . Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy. Thromb Res. 2015; 135(5):861-6. DOI: 10.1016/j.thromres.2015.02.019. View

5.
Roth J, Boudreau D, Fujii M, Farin F, Rettie A, Thummel K . Genetic risk factors for major bleeding in patients treated with warfarin in a community setting. Clin Pharmacol Ther. 2014; 95(6):636-43. PMC: 4067047. DOI: 10.1038/clpt.2014.26. View